Abstract
Background
To report a rare occurrence of pigment epitheliopathy associated with choroidal neovasculization as a first manifestation of systemic lupus erythematosus.
Case presentation
A 54-year-old female, with no prior medical history, sought a second opinion due to sudden drop in vision in her right eye to 20/80. Slit lamp examination was normal. Fundus examination revealed the presence of a subretinal hemorrhage in the macular area. Fundus imaging including optical coherence tomography and fluorescein angiography showed multifocal retinal pigment epitheliopathy associated with choroidal neovascularization (CNV). The patient had received an intravitreal injection of Bevacizumab 2 weeks ago. It was decided to complete the loading dose regimen with two additional Bevacizumab injections, and the first injection was done 2 weeks after her presentation. Two weeks later, the patient reported a rash on her cheeks, painful joints, and purpura. Systemic workup revealed positive ANA, anti-cardiolipin antibodies, and decreased complement levels, with negative anti-histone antibodies. This led to the diagnosis of systemic lupus erythematosus (SLE) based on the “Systemic Lupus International Collaborating Clinics” criteria. The patient was treated with 50 mg of prednisolone which was then tapered. 1 month after the third injection, an showed a total resolution of the sub-retinal fluid with an improvement of vision to 20/20. No recurrence was observed during follow-up.
Conclusion
Based on the findings from the fundus exam and imaging, systemic symptoms and the blood work-up, we postulate that the pigment epitheliopathy associated with choroidal neovascularization was related to the vaso-occlusive disease at the level of the choroid that can be part of SLE vasculopathy. To our knowledge, this represents the first case in which pigment epitheliopathy and CNV were the primary manifestations of SLE.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
Data availability
No datasets were generated or analysed during the current study.
References
Fava A, Petri M (2019) Systemic lupus erythematosus: diagnosis and clinical management. J Autoimmun 96:1–13. https://doi.org/10.1016/J.JAUT.2018.11.001
Luboń W, Luboń M, Kotyla P, Mrukwa-Kominek E (2022) Understanding ocular findings and manifestations of systemic lupus erythematosus: update review of the literature. Int J Mol Sci 23(20):12264. https://doi.org/10.3390/ijms232012264
Cunningham J, Alfred PR, Irvine AR (1996) Central serous chorioretinopathy in patients with systemic lupus erythematosus. Ophthalmology 103(12):2081–2090. https://doi.org/10.1016/S0161-6420(96)30385-0
Grossniklaus HE, Green WR (2004) Choroidal neovascularization. Am J Ophthalmol 137(3):496–503. https://doi.org/10.1016/J.AJO.2003.09.042
Invernizzi A et al (2019) Five-year real-world outcomes of occult and classic choroidal neovascularization: data from the fight retinal blindness! project. Am J Ophthalmol 204:105–112. https://doi.org/10.1016/J.AJO.2019.03.001
Journal O, Gallego-Pinazo R, Dolz-Marco R, Gómez-Ulla F, Mrejen S, Freund B (2014) Pachychoroid diseases of the macula. Med Hypothesis, Discov Innov Ophthalmol 3(4):111
de Azevedo LGB et al (2021) Lupus retinopathy: epidemiology and risk factors. Arq Bras Oftalmol 84(4):395–401. https://doi.org/10.5935/0004-2749.20210076
Seth G et al (2018) Lupus retinopathy: a marker of active systemic lupus erythematosus. Rheumatol Int 38(8):1495–1501. https://doi.org/10.1007/S00296-018-4083-4
Stafford-Brady FJ, Urowitz MB, Gladman DD, Easterbrook M (1988) Lupus retinopathy. Patterns, associations, and prognosis. Arthritis Rheum 31(9):1105–1110. https://doi.org/10.1002/ART.1780310904
Papagiannuli E, Rhodes B, Wallace GR, Gordon C, Murray PI, Denniston AK (2016) Systemic lupus erythematosus: an update for ophthalmologists. Surv Ophthalmol 61(1):65–82. https://doi.org/10.1016/J.SURVOPHTHAL.2015.06.003
Jabs DA, Fine SL, Hochberg MC, Newman SA, Heiner GG, Stevens MB (1986) Severe retinal vaso-occlusive disease in systemic lupus erythematous. Arch Ophthalmol 104(4):558–563. https://doi.org/10.1001/ARCHOPHT.1986.01050160114025
Ushiyama O et al (2000) Retinal disease in patients with systemic lupus erythematosus. Ann Rheum Dis 59(9):705–708. https://doi.org/10.1136/ARD.59.9.705
Vihinen P, Paija O, Kivisaari A, Koulu L, Aho H (2011) Cutaneous lupus erythematosus after treatment with paclitaxel and bevacizumab for metastatic breast cancer: a case report. J Med Case Rep 5:243. https://doi.org/10.1186/1752-1947-5-243
cutaneous lupus erythematosus in a patient undergoing intravitreal bevacizumab injections: case report and review of the literature—jddonline—journal of drugs in dermatology. https://jddonline.com/articles/cutaneous-lupus-erythematosus-in-a-patient-undergoing-intravitreal-bevacizumab-injections-case-repor-S1545961613P1052X. Accessed 26 Mar 2023
FIRST AID FOR THE USMLE STEP 2 CK, 10th edn. McGraw Hill
Chan S, Gottlieb CC (2015) Systemic lupus erythematosus presenting as acute posterior multifocal placoid pigment epitheliopathy case report and review of the ocular manifestations of systemic lupus erythematosus. Int J Ophthalmol Clin Res 2:4–12
Sawa M, Saito Y, Kameda C, Tano Y (2002) Ocular complications in systemic lupus erythematosus–choroidal and retinal pigment epithelial changes. Nihon Ganka Gakkai Zasshi 106(8):474–480. https://doi.org/10.1016/s0021-5155(02)00657-3
Savastano MC, Rispoli M, Lumbroso B (2021) The incidence of neovascularization in central serous chorioretinopathy by optical coherence tomography angiography. Retina 41(2):302–308. https://doi.org/10.1097/IAE.0000000000002810
Raja L et al (2020) Choroidal neovascularization mimics in chronic central serous chorioretinopathy; an optical coherence tomography angiography study. Invest Ophthalmol Vis Sci 61(7):4811–4811
Kim RY, Ma GJ, Park WK, Kim M, Park YG, Park YH (2021) Clinical course after the onset of choroidal neovascularization in eyes with central serous chorioretinopathy. Medicine (Baltimore) 100(34):E26980. https://doi.org/10.1097/MD.0000000000026980
Funding
The authors declare that no funds, grants, or other support were received during the preparation of this manuscript.
Author information
Authors and Affiliations
Contributions
All authors contributed to the study conception and design. Material preparation, data collection and analysis were performed by Carla Abi Doumit, Edmond Jalkh. The first draft of the manuscript was written by Edmond Jalkh and all authors commented on previous versions of the manuscript. All authors read and approved the final manuscript.
Corresponding author
Ethics declarations
Conflict of interest
The authors have no relevant financial or non-financial interests to disclose.
Ethical approval
This study was performed in line with the principles of the Declaration of Helsinki. Approval was granted by the Ethics Committee of the Eye and Ear Hospital International.
Consent to participate
Informed consent was obtained from all individual participants included in the study.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Jalkh, E., Abi Doumit, C., Schakal, A. et al. A case of choroidal neovascularization as a first manifestaion of systemic lupus erythematosus. Int Ophthalmol 44, 212 (2024). https://doi.org/10.1007/s10792-024-03120-x
Received:
Accepted:
Published:
DOI: https://doi.org/10.1007/s10792-024-03120-x